Cargando…
Centrality of drug targets in protein networks
BACKGROUND: In the pharmaceutical industry, competing for few validated drug targets there is a drive to identify new ways of therapeutic intervention. Here, we attempted to define guidelines to evaluate a target’s ‘fitness’ based on its node characteristics within annotated protein functional netwo...
Autor principal: | Viacava Follis, Ariele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555226/ https://www.ncbi.nlm.nih.gov/pubmed/34715787 http://dx.doi.org/10.1186/s12859-021-04342-x |
Ejemplares similares
-
Regulation of apoptosis by an intrinsically disordered region of Bcl-xL
por: Follis, Ariele Viacava, et al.
Publicado: (2018) -
Identification and Characterization of an Allosteric
Inhibitory Site on Dihydropteroate Synthase
por: Hammoudeh, Dalia I., et al.
Publicado: (2014) -
PUMA Binding Induces Partial Unfolding within BCL-xL to Disrupt p53 Binding and Promote Apoptosis
por: Follis, Ariele Viacava, et al.
Publicado: (2013) -
Centrality Analysis of Protein-Protein Interaction Networks and Molecular Docking Prioritize Potential Drug-Targets in Type 1 Diabetes
por: Soofi, Asma, et al.
Publicado: (2020) -
REEXAMINING RACE AND ETHNICITY FROM A STRUCTURAL RACISM AND SOCIAL DETERMINANTS OF HEALTH LENS IN COHORT STUDIES
por: Follis, Shawna
Publicado: (2022)